Coronary heart disease and estrogen replacement therapy can compliance bias explain the results of observational studies?

This publication has 10 references indexed in Scilit:

• The relationship of treatment adherence to the risk of death after myocardial infarction in women
  JAMA, 1993
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
  Annals of Internal Medicine, 1992
• A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer
  JAMA, 1991
• Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
  Preventive Medicine, 1991
• Treatment adherence and risk of death after a myocardial infarction
  The Lancet, 1990
• Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug Project
  New England Journal of Medicine, 1980
• Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems
  Obstetrics & Gynecology, 1979
• Clofibrate and niacin in coronary heart disease
  JAMA, 1975
• The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group
  Published by American Medical Association (AMA) ,1973
• The Coronary Drug Project. Initial findings leading to modifications of its research protocol
  JAMA, 1970